Jinhai International Group Holdings Limited (HK:2225) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jinhai Medical Technology Limited has entered into a master sales agreement with Sinopharm Holdings Lingshang Hospital Management Services, which will serve as the exclusive distributor of Jinhai’s high-end medical devices in China until October 2025. This partnership aims to leverage Sinopharm’s extensive distribution network to enhance Jinhai’s market presence and boost growth in the medical industry. With products like 4K3D fluorescent endoscopes showing strong potential, the company anticipates this collaboration will significantly expand market share and enhance shareholder returns.
For further insights into HK:2225 stock, check out TipRanks’ Stock Analysis page.